200 related articles for article (PubMed ID: 6696240)
1. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
Ruhland G; Hinkle AJ
Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
[No Abstract] [Full Text] [Related]
2. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
[No Abstract] [Full Text] [Related]
3. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
Jantzen JP; Erdmann K; Kleemann PP
Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
[TBL] [Abstract][Full Text] [Related]
4. Malignant hyperthermia in a patient receiving nitrous oxide.
Waite PD; Ballard JB; Yonfa A
J Oral Maxillofac Surg; 1985 Nov; 43(11):907-9. PubMed ID: 3863903
[TBL] [Abstract][Full Text] [Related]
5. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
6. General anesthesia in a malignant hyperthermia susceptible patient.
Jones JE; Dierdorf SF; Clapp DW
J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
[No Abstract] [Full Text] [Related]
7. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
[No Abstract] [Full Text] [Related]
8. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
Harrison GG
Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
[TBL] [Abstract][Full Text] [Related]
9. [Sodium dantrolene].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
[No Abstract] [Full Text] [Related]
10. Plasma levels of dantrolene following oral administration in malignant hyperthermia-susceptible patients.
Allen GC; Cattran CB; Peterson RG; Lalande M
Anesthesiology; 1988 Dec; 69(6):900-4. PubMed ID: 3057938
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
12. Dantrolene for malignant hyperthermia during anesthesia.
Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
[No Abstract] [Full Text] [Related]
13. [Malignant hyperthermia: pharmacogenetically caused acute massive rhabdomyolysis].
Lebedinskiĭ KM; Triadskiĭ AA; Obolenskiĭ SV
Anesteziol Reanimatol; 2008; (4):66-70. PubMed ID: 18819397
[No Abstract] [Full Text] [Related]
14. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
Bernhardt D
Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
[TBL] [Abstract][Full Text] [Related]
15. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
[TBL] [Abstract][Full Text] [Related]
16. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
[TBL] [Abstract][Full Text] [Related]
17. Malignant hyperthermia. Considerations for the ophthalmologist.
Sedwick LA; Romano PE
Surv Ophthalmol; 1981; 25(6):378-82. PubMed ID: 7245023
[TBL] [Abstract][Full Text] [Related]
18. [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Itoh K; Nishibe S; Usuda Y; Kitamura A
Masui; 2014 Oct; 63(10):1153-5. PubMed ID: 25693350
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia in the absence of triggering agents.
Setzer-Saade N
Anesth Analg; 2010 Sep; 111(3):822; author reply 822-3. PubMed ID: 20733170
[No Abstract] [Full Text] [Related]
20. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
